Gui Liberali

Gui Liberali

Auto-generated profile, based on publicly available information

Gui Liberali

Erasmus University, Rotterdam School of Management, Rotterdam, The Netherlands; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Marketing Science
Verified
Journal Article
Closed access
GLGui Liberali
Gui Liberali
AFAlina Ferecatu
Alina Ferecatu
In this paper, the authors propose and validate a multiarmed bandit model that dynamically adapts website design to match a user's changing position in the purchase funnel.

1 March 2022 in Management Science
Verified
Journal Article
Closed access
KGKay Giesecke
Kay Giesecke
GLGui Liberali
Gui Liberali
HNHamid Nazerzadeh
Hamid Nazerzadeh
JSJ. George Shanthikumar
J. George Shanthikumar
CTChung Piaw Teo
Chung Piaw Teo

16 November 2024 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
GLGui Liberali
Gui Liberali
EBEric Boersma
Eric Boersma
HLHester Lingsma
Hester Lingsma
JBJasper Brugts
Jasper Brugts
DDDiederik Dippel
Diederik Dippel
JHJohn Hauser
John Hauser
To evaluate real-time (day-to-day) adaptation of randomized controlled trials (RCTs) with delayed endpoints - a "forward-looking optimal-experimentation" form of response-adaptive randomization. To identify the implied tradeoffs between lowered mortality, CIs, statistical power, potential arm misidentification, and endpoint rate change during the trial. Using data from RCTs in acute myocardial infarction (30,732 patients in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries, GUSTO-1) and coronary heart disease (12,218 patients in the EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease, EUROPA), we resample treatment-arm assignments and expected endpoints to simulate (1) real-time assignment, (2) forward-looking assignments adapted after observing a fixed number of patients ("blocks"), and (3) a variant that balances RCT and real-time assignments. Blinded real-time adaptive randomizations (RTARs) adjust day-to-day arm assignments by optimizing the tradeoff between assigning the (likely) best treatment and learning about endpoint rates for future assignments. Despite delays in endpoints, real-time assignment quickly learns which arm is superior. In the simulations, by the end of the trials, real-time assignment allocated more patients to the superior arm and fewer patients to the inferior arm(s) resulting in less mortality over the course of the trial. Endpoint rates and odds ratios were well within (resampling) CIs of the RCTs, but with tighter CIs on the superior arm and less-tight CIs on the inferior arm(s) and the odds ratios. The variant and patient-block-based adaptation each provides intermediate levels of benefits and costs. When endpoint rates change within a trial, real-time assignment improves estimation of the end-of-trial superior-arm endpoint rates, but exaggerates differences relative to inferior arms. Unlike most response-adaptive randomizations, real-time assignment automatically adjusts to reduce biases when real changes are larger. Real-time assignment improves patient outcomes within the trial and narrows the CI for the superior arm. Benefits are balanced with wider CIs on inferior arms and odds ratios. Forward-looking variants provide intermediate benefits and costs. In no simulations, was an inferior arm identified as statistically superior. Randomized controlled trials (RCT) are the gold standard in clinical trials - typically half of the patients are assigned to a new drug or procedure and the other half to a placebo (or the current best option). Typically, half of the patients might get an inferior drug or treatment. We explore a method, real-time adaptive randomization (RTAR), that uses information observed up to the time of the next assignment to best allocate patients to treatments, balancing known current and unknown future outcomes-treating vs. learning. RTAR is based on a preplanned, but adaptive, assignment rule. Blinding can be maintained, so that neither the trialist nor the patient knows to which treatment the patient was assigned. During the trial, as the RTAR learns the "best" treatment, the RTAR assigns more patients to that best treatment than would a classical RCT. In two large-scale cardiovascular clinical trials, our simulations suggest that the RTAR would have saved lives while identifying the best post-trial treatment at least as well as an RCT. Some statistical measures are improved and others are worse. If endpoint rates in treatments would have changed dramatically during the trial, the RTAR would have adapted better than many other methods.

14 July 2017
Verified
Book Chapter
Closed access
PDF file
GLGui B. Liberali
Gui B. Liberali
JHJohn R. Hauser
John R. Hauser
GUGlen L. Urban
Glen L. Urban

8 November 2019 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
GLGui Liberali
Gui Liberali
AFAlina Ferecatu
Alina Ferecatu
Websites that match the information needs of visitors are efficient, but information needs may change as visitors browse a website. When consumers visit online stores they are exposed to information that may help them move along the purchase funnel, or make them bounce and leave the website. The position in the funnel is not directly observed, so learning from the outcome of a visit is a major challenge for multi-armed bandit models used in website design and online advertising. We develop a novel dynamic program to explicitly model the trade-off that the firm faces between nudging a visitor to later states along the funnel, and maximizing immediate expected reward given the current-state purchase probabilities. We use a hidden Markov model to dynamically assess the consumers stages based on clickstream, and couple it with a website- morphing multi-armed bandit model to learn the effectiveness of each design-stage combination using a dynamic allocation index. We provide a proof-of-concept based on adapting the full-time MBA website of a major European university. In this application, a team designed morphs based on categorization and construal-level theories, which provides us with substantive support for the choice of morph content and language tailored for early and late stages of the funnel. We find that matching concrete and abstract morphs to dynamic states using our algorithm outperforms current methods based on non-dynamic policies and HMM policies that are agnostic to the trade-off between bouncing and nudging.

1 January 2012 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
GLGui Liberali
Gui Liberali
GUGlen L. Urban
Glen L. Urban
JHJohn R. Hauser
John R. Hauser
Two field experiments examine whether providing information to consumers about competitive products builds trust. Established theory suggests that (1) competiti